Senseonics Signs Memorandum of Understanding with Ascensia Diabetes Care to Take Over Commercialization and Distribution of Eversense 365
1. Senseonics transitions commercialization of Eversense 365 back in-house. 2. Brian Hansen appointed as new Chief Commercial Officer starting January 2026. 3. Non-dilutive debt facility expanded to $100 million for operational funding. 4. 2025 revenue expected to reach $34-38 million, with margin growth projections. 5. Conference call scheduled for September 4 to discuss transition details.